Discover published sets by community

Medications to prevent organ rejection, including calcineurin inhibitors, antiproliferative agents, and corticosteroids.

Ongoing vigilance for signs of acute or chronic rejection, potentially necessitating biopsy and alterations in immunosuppressive therapy.

Counseling and support groups to help patients adapt to life post-transplant and cope with stress and medication adherence.

Management of bone health through vitamin D supplementation, phosphorus control, and monitoring parathyroid hormone (PTH) levels.

Post-transplant diabetes can arise due to immunosuppressive medications; management includes insulin or oral hypoglycemics.

Changes in diet and exercise to support overall health and graft function, such as low salt intake and regular physical activity.

Monitoring for CKD progression post-transplant by evaluating the kidney's structure and function over time.

Prevention of post-transplant infections through antimicrobial agents such as antibacterials, antivirals, and antifungals.

Control of blood pressure through antihypertensive medications to reduce the risk of graft dysfunction and cardiovascular complications.

Increased risk of cancer post-transplant requires vigilant screening protocols for early detection.

Regular assessment of graft function through laboratory tests such as serum creatinine levels and glomerular filtration rate (GFR).